Improving risk evaluation and outcomes in childhood leukaemia

改善儿童白血病的风险评估和结果

• 批准号: nhmrc : GNT1057746
• 负责人: A/Pr Rosemary Sutton
• 金额: $ 77.16万
• 依托单位国家: 澳大利亚
• 项目类别: Project Grants
• 财政年份: 2014
• 资助国家: 澳大利亚
• 起止时间: 2014-01-01 至 无数据
• 项目状态: 已结题
• 来源: https://researchdata.edu.au/improving-risk-evaluation-childhood-leukaemia/1344618
• 关键词: Improving; risk; evaluation; outcomes; childhood

The main objective of this project is to make substantial improvements in the treatment of patients with childhood leukaemia by greater use of molecular diagnostics to measure minimal residual disease (MRD) and high risk genetic changes in Australian patients enrolled on an international clinical trial which has been designed to reduce the incidence of both relapses and long term side-effects.

该项目的主要目标是通过更多地使用分子诊断来测量参加国际临床试验的澳大利亚患者的最小残留疾病（MRD）和高风险遗传变化，从而大大改善儿童白血病患者的治疗，该试验旨在减少复发和长期副作用的发生率。